Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.
A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.
Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.
More top news
NFU Mutual has found the cost of rural crime in our region rose by a fifth last year, despite a decrease nationally.
The victim was walking her dog last month in an area known to locals as 'Black Bobby's Field'.
Lewis Kerr collided with another rider before hitting a fence during a race meeting in Peterborough.